Valuation: ResMed, Inc.

Capitalization 3.73TCr 3.23TCr 3.03TCr 2.76TCr 5.12TCr 3,22600Cr 5.79TCr 36TCr 14TCr 1,48000Cr 14TCr 14TCr 5,45300Cr P/E ratio 2025 *
27.4x
P/E ratio 2026 * 24.9x
Enterprise value 3.69TCr 3.19TCr 3TCr 2.73TCr 5.06TCr 3,19200Cr 5.73TCr 36TCr 14TCr 1,46400Cr 14TCr 14TCr 5,39500Cr EV / Sales 2025 *
7.19x
EV / Sales 2026 * 6.49x
Free-Float
76.64%
Yield 2025 *
0.85%
Yield 2026 * 0.98%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.18%
1 week+1.29%
Current month+3.48%
1 month+2.88%
3 months+13.64%
6 months+8.92%
Current year+10.77%
More quotes
1 week 249.6
Extreme 249.6
255.46
1 month 239.94
Extreme 239.935
255.46
Current year 199.92
Extreme 199.92
263.05
1 year 180.34
Extreme 180.34
263.05
3 years 132.24
Extreme 132.24
263.05
5 years 132.24
Extreme 132.24
301.34
10 years 48.99
Extreme 48.99
301.34
More quotes
Manager TitleAgeSince
Chief Executive Officer 52 01/03/2013
Director of Finance/CFO 58 01/01/2006
Compliance Officer - 01/01/2018
Director TitleAgeSince
Director/Board Member 75 25/08/2005
Director/Board Member 77 01/01/2005
Chairman 52 25/01/2023
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.17%+1.29%+39.03%+19.77% 3.73TCr
-0.34%+0.24%+19.64%+144.82% 18TCr
+0.02%+0.51%+33.29%+168.94% 15TCr
+0.61%+3.15%-28.87%-26.11% 15TCr
+0.28%+0.45%-23.42%-23.44% 14TCr
+0.70%+1.79%-12.73%-0.30% 5.99TCr
-0.31%+1.16%-17.80%-23.57% 4.42TCr
-0.63%-4.56%-22.39%-27.31% 3.8TCr
+0.96%+0.57%-13.57%-3.74% 3.3TCr
+1.34%+0.96%-8.91% - 3.26TCr
Average +0.24%-0.68%-3.57%+25.45% 8.73TCr
Weighted average by Cap. +0.16%-0.53%-0.77%+51.90%
See all sector performances

Financials

2025 *2026 *
Net sales 512.5Cr 444.03Cr 416.46Cr 379.6Cr 703.7Cr 44TCr 796.11Cr 4.94TCr 1.9TCr 20TCr 1.92TCr 1.88TCr 75TCr 554.24Cr 480.19Cr 450.38Cr 410.52Cr 761.01Cr 48TCr 860.96Cr 5.34TCr 2.05TCr 22TCr 2.08TCr 2.04TCr 81TCr
Net income 136.28Cr 118.07Cr 110.74Cr 100.94Cr 187.12Cr 12TCr 211.69Cr 1.31TCr 504.83Cr 5.41TCr 511.35Cr 500.47Cr 20TCr 150.52Cr 130.41Cr 122.31Cr 111.49Cr 206.67Cr 13TCr 233.81Cr 1.45TCr 557.58Cr 5.98TCr 564.79Cr 552.76Cr 22TCr
Net Debt -40Cr -34Cr -32Cr -29Cr -54Cr -3.42TCr -61Cr -380.65Cr -146.39Cr -1.57TCr -148.28Cr -145.13Cr -5.78TCr -127.89Cr -110.8Cr -103.92Cr -95Cr -175.6Cr -11TCr -198.66Cr -1.23TCr -473.74Cr -5.08TCr -479.86Cr -469.64Cr -19TCr
More financial data * Estimated data
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (50.4%); - masks (37.9%); - software as a service (11.7%). At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia. The United States accounts for 61.4% of net sales.
Employees
9,980
More about the company
Date Price Change Volume
24/25/24 253.56 $ -0.38% 65,144
23/25/23 254.52 $ +0.33% 5,91,314
20/25/20 253.68 $ +1.12% 9,64,362
18/25/18 250.88 $ +0.32% 6,35,899
17/25/17 250.09 $ -0.63% 6,68,450

Delayed Quote Nyse, June 24, 2025 at 07:33 pm IST

More quotes
Trading Rating
Investor Rating
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
254.52USD
Average target price
264.49USD
Spread / Average Target
+3.92%
Consensus

Quarterly revenue - Rate of surprise